In recent years, research on the interaction between flavonoids and intestinal microbes have prompted a rash of food science, nutriology and biomedicine, complying with future research trends. The gut microbiota plays an essential role in the maintenance of intestinal homeostasis and human health, but once the intestinal flora dysregulation occurs, it may contribute to various diseases. Flavonoids have shown a variety of physiological activities, and are metabolized or biotransformed by gut microbiota, thereby producing new metabolites that promote human health by modulating the composition and structure of intestinal flora. Herein, this review demonstrates the key notion of flavonoids as well as intestinal microbiota and dysbiosis, aiming to provide a comprehensive understanding about how flavonoids regulate the diseases by gut microbiota. Emphasis is placed on the microbiota-flavonoid bidirectional interaction that affects the metabolic fate of flavonoids and their metabolites, thereby influencing their metabolic mechanism, biotransformation, bioavailability and bioactivity. Potentially by focusing on the abundance and diversity of gut microbiota as well as their metabolites such as bile acids, we discuss the influence mechanism of flavonoids on intestinal microbiota by protecting the intestinal barrier function and immune system. Additionally, the microbiota-flavonoid bidirectional interaction plays a crucial role in regulating various diseases. We explain the underlying regulation mechanism of several typical diseases including gastrointestinal diseases, obesity, diabetes and cancer, aiming to provide a theoretical basis and guideline for the promotion of gastrointestinal health as well as the treatment of diseases.

Two hundred and forty 1-d-old Arbor Acre female broilers were used to study the effects of alfalfa flavonoids (AF) on broiler performance, meat quality, and gene expression. Chicken were fed with basal diet supplemented with AF at 0, 5, 10, or 15 mg kg⁻¹ diet for a period of 42 d. Growth performance, meat quality, antioxidant effect and lipoprotein lipase (LPL), adipose triglyceride lipase (ATGL), peroxisome proliferator-activated receptor γ (PPARγ), and fatty acid synthase (FAS) gene expressions were investigated. Results showed that AF inclusion in the diet enhanced the body weight (BW) at 42 d of age and the average daily gain from 0 to 42 d, decreased the total cholesterol (TC) and low-density lipoprotein cholesterol (LDL) levels and increased HDL level in the serum, enhanced the superoxide dismutase (SOD), catalase (CAT), total antioxidant capacity (T-AOC), and glutathione peroxidase (GSH-Px), and decreased the malondialdehyde (MDA) concentrations in the serum. Also, AF supplementation decreased the abdomen fat rate, marble, and the drip loss and storage loss after the storage for 96 h. Gene expressions’ results showed that AF inclusion decreased the FAS expression and increased the LPL, PPARγ, and ATGL expressions in the liver and adipose tissues, especially when the AF inclusion level was 15 mg kg⁻¹ diet. These results indicate that AF were found to be effective for average daily gain and breast percentage promoting, meat quality and antioxidant activity improvement via upregulating the LPL, ATGL, PPARγ, and downregulating the FAS expression in adipose and liver tissues.